# Dexmetomidine With Erector Spinae Plane Block in Cholecystectomy

> **NCT05369468** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 60 (actual)

## Conditions studied

- Dexmedtomidine in Erector Spinae Block for Laparscopic Cholecystectomy

## Interventions

- **DRUG:** dexmedetomidine as adjuvant with bupivacaine
- **DRUG:** Bupivacain only

## Key facts

- **NCT ID:** NCT05369468
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-22
- **Primary completion:** 2022-11-10
- **Final completion:** 2022-11-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05369468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05369468, "Dexmetomidine With Erector Spinae Plane Block in Cholecystectomy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05369468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*